The University held a public forum on COVID-19 on Thursday 12th March 2020 at the Chandaria Auditorium, UoN Towers.
The forum brought together staff, students and members of the public to discuss the impact of COVID-19 and potential solutions.
On 10th January 2020, we hosted a delegation of students and teachers from Linnankoski High school and Linnajoki secondary school in Porvoo, Finland. The delegation was an educational tour; with a focus on the effects of climate change and health.
We are pleased to announce the first Institut Mérieux – KAVI-Institute of Clinical Research Young Investigator Award Winner, Dr Loice Achieng.
The New Year started on 24th January 2020 for KAVI-ICR Journal club with Professor Jason Kindrachuk from the Department of Medical Microbiology & Infectious Diseases, University of Manitoba, Presenting on Ebola Virus. The presentation was titled 'Identifying the molecular determinants underlying Ebola virus persistence in incidental and reservoir hosts.' The KAVI-ICR Journal club brings together scientists and students twice a month to listen to presentations of various projects.
World AIDs Day is a global event marked on the 1st of December each year. The occasion is held in support of People Living with HIV/AIDs, to commemorate those who have passed on due to HIV/AIDs related causes as well as celebrating the success and advancements made in the last decades in the prevention/management of HIV.
Newly emerging pathogens including bacterial pathogens with emerging resistance to current antimicrobial agents pose a major public health problem globally. There is an urgent need for more trans-disciplinary and trans-sectorial approaches to prioritize and tackle this emerging public health problem.
On 24th September 2019, the first volunteer was enrolled in the IAVI-W001 study at the KAVI-Institute of Clinical Research (KAVI-ICR) of the University of Nairobi. The occasion marks the beginning of the 12th HIV vaccine clinical trial to be conducted at KAVI-ICR since 2001. This is a first-in-human study that uses a Native-trimer HIV envelope design that will hopefully stimulate broadly neutralizing antibodies against HIV.
